Clinical Trial Update: A Randomized Trial of Pembrolizumab & Radiotherapy Versus Radiotherapy in High-Risk Soft Tissue Sarcoma of the Extremity [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial evaluating pembrolizumab plus radiotherapy versus radiotherapy alone in high-risk soft tissue sarcoma of the extremity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma of the Extremity

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Sarcoma Alliance for Research through Collaboration | Conditions: Soft Tissue Sarcoma of the Extremity | Phase 2 | Status: ACTIVE_NOT_RECRUITING